GMED Stock Score & AI Analysis
AI-scored July 16, 2026 · 15-dimension engine · 30+ data sources
GMED scores 26/100 — SELL. Strongest on fundamentals, weakest on earnings.
Why GMED scores 26
- MACD bearish crossover
- Price below key moving averages
- PEG undervalued (0.08)
Strongest dimension: fundamentals · Weakest: earnings
See the full 15-dimension breakdown for GMED
Every component score, the full research report, trade plan, options flow, insider & congressional activity — updated every morning before the bell.
Start Free Trial →GMED — frequently asked
Our AI engine currently rates GMED SELL, with a composite score of 26/100 across 15 dimensions. This is software-generated analysis, not personalized investment advice.
GMED scores 26 out of 100 — in the top 74% of the 1,000+ stocks we screen. The score blends technicals, fundamentals, sentiment, momentum, smart-money flow, options flow, earnings, and insider activity.
Wall Street Analyst reads 30+ live data sources every morning and scores GMED on a 15-dimension engine. The full per-dimension breakdown and research report are available to members.
Wall Street Analyst is financial software and education — not personalized investment advice, and we are not a registered investment advisor. Scores are model-generated and update daily. Markets carry risk; past results don't guarantee future ones, and every decision is yours.